Complement regulatory proteins: Are they important in disease?

Journal of the American Society of Nephrology

Volumn 14, Issue 9, 2003, Pages 2411-2413

  Nangaku, Masaomi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; NEUTRALIZING ANTIBODY; REGULATOR PROTEIN;

COMPLEMENT ACTIVATION; EDITORIAL; GLOMERULONEPHRITIS; HEMOLYSIS; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNE INJURY; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL;

EID: 0042821619     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000088010.15313.A1     Document Type: Editorial

References (37)

1. Turnberg D, Botto M, Warren J, Morgan BP, Walport MJ, Cook HT CD59a deficiency exacerbates accelerated nephrotoxic nephritis in mice. J Am Soc Nephrol 14: 2271-2279, 2003
2. Couser WG: Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 13[Suppl 1]: 10-15, 1998
3. Couser WG: Pathogenesis of glomerulonephritis. Kidney Int 42[Suppl]: S19-26, 1993
4. Nangaku M: Final common pathways of progression of renal diseases. Clin Exp Nephrol 6: 182-189, 2002
5. Nangaku M: Mechanisms of tubulointerstitial injury in the kidney. Intern Med 2003, in press
6. Nangaku M: Complement regulatory proteins in glomerulonephritis. Kidney Int 54, 1419-1428, 1998
7. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M: Uncontrolled C3 activation causes membrano-proliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31, 424-428, 2002
8. Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HPH, Remuzzi G, Zipfel PF: Mutations in factor H reduce binding affinity of C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111: 1181-1190, 2003
9. Lin RC, Herman J, Henry L, Daniels GL: A family showing inheritance of the Inab phenotype. Transfusion 28: 427-429, 1988
10. Telen MJ, Green AM: The Inab phenotype: Characterization of the membrane protein and complement regulatory defect. Blood 74: 437-441, 1989
11. Reid ME, Mallinson G, Sim RB, Poole J, Pausch V, Merry AH, Liew YW, ReTanner MJ: Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 78: 3291-3297, 1991
12. Yamashita M, Ueda E, Kinoshita T, Takami T, Ojima A, Ono H, Tanaka H, Kondo N, Orii T, Okada N, Okada H, Inoue K, Kitani T: Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. New Engl J Med 323: 1184-1189, 1990
13. Shichishima T, Saitoh T, Terasawa T, Noji H, Kai T, Maruyama Y: Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype. Br J Haemat 104: 303-306, 1999
14. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, Morgan BP, Sara JP, Nadai M, Hasegawa T, Matsuo S: Tubulointerstitial injury induced in rats by a monoclonal antibody which inhibits function of a membrane inhibitor of complement. J Clin Invest 96: 2348-2356, 1995
15. Matsuo S, Ichida S, Takizawa H, Okada N, Baranyi L, Iguchi A, Morgan BP. Okada H: In vivo effects of monoclonal antibodies which functionally inhibit complement regulatory proteins in rats. J Exp Med 180: 1619-1627, 1994
16. Watanabe M, Morita Y, Mizuno M, Nishikawa K, Yuzawa Y, Hotta N, Morgan BP, Okada N, Okada H, Matsuo S: CD59 protects rat kidney from complement mediated injury in collaboration with Crry. Kidney Int 58: 1569-1579, 2000
17. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, Morgan BP, Johnson RJ, Couser WG: CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats. J Am Soc Nephrol 9: 590-597, 1998
18. Matsuo S, Nishikage H, Yoshida F, Nomura A, Piddlesden SJ, Morgan BP: Role of CD59 in experimental glomerulonephritis in rats. Kidney Int 46: 191-200, 1994
19. Cunningham PN, Hack BK, Ren G, Minto AWM, Morgan BP, Quigg RJ: Glomerular complement regulation is overwhelmed in passive Heymann nephritis. Kidney Int 60: 900-909, 2001
20. Hanafusa N, Sogabe H, Yamada K, Wada T, Fujita T, Nangaku M: Contribution of genetically engineered animals to the analyses of complement in the pathogenesis of nephritis. Nephrol Dial Transplant 17[Suppl 9], 34-36, 2002
21. Sogabe H, Nangaku M, Ishibashi Y, Wada T, Fujita T, Sun X, Miwa T, Madaio MP, Song W: Increased susceptibility of decay-accelerating factor (DAF) deficient mice to anti-GBM glomerulonephritis. J Immunol 167: 2791-2797, 2001
22. Lin F, Emancipator SN, Salant DJ, Medof ME: Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab Invest 82: 563-569, 2002
23. Bao L, Haas M, Boackle SA, Kraus DM, Cunningham PN, Park P, Alexander JJ, Anderson RK, Culhane K, Holers VM, Quigg RJ: Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J Immunol 168: 3601-3607, 2002
24. Schiller B, Cunningham PN, Alexander JJ, Bao L, Holers VM, Quigg RJ: Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure. J Am Soc Nephrol 12: 71-79, 2001
25. Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM: Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med. 188: 1321-1331, 1998
26. Miwa T, Zhou L, Hilliard B, Molina H, Song WC Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707-3716, 2002
27. Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP: Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98: 442-449, 2001
28. Acosta J, Hettinga J, Fluckiger R, Krumrei N, Goldfine A, Angarita L, Halperin J: Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci 97: 5450-5455, 2000
29. Qin X, Krumrei N, Grubissich L, Dobarro M, Aktas H, Perez G, Halperin JA: Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility. Immunity 18: 217-227, 2003
30. Couser WG, Johnson RJ, Young BA, Yeh G, Toth CA, Rudolph AR: The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J Am Soc Nephrol 5: 1888-1894, 1995
31. Bao L, Haas M, Kraus DM, Hack BK, Rakstang JK, Holers VM, Quigg RJ: Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol 14: 670-679, 2003
32. Sogabe R, Quigg RJ, Okada N, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M: Gene therapy for renal injury model rat using an adenovirus vector encoding the soluble rat Crry gene. Clin Exp Nephrol 6: 216-223, 2002
33. Harris CL, Williams AS, Linton SM, Morgan BP: Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo. Clin Exp Immunol 129: 198-207, 2002
34. Song H, He C, Knaak C, Guthridge JM, Holers VM, Tomlinson S: Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J Clin Invest 111: 1875-1885, 2003
35. Zhang HF, Yu J, Bajwa E, Morrison SL, Tomlinson S: Targeting of functional antibody-CD59 fusion proteins to a cell surface. J Clin Invest 103: 55-61. 1999
36. Nangaku M, Pippin J, Couser WG: C6 mediates chronic progression of tubulointerstitial damage in remnant kidney rats. J Am Soc Nephrol 13: 928-936, 2002
37. Nangaku M, Pippin J, Couser WG: Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 10: 2323-2331, 1999